Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Pancreatic cancer | R-HSA-9700206 | map05212 | celastrol | 5478883 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | celastrol | 5478883 | drug-path |
Asthma | R-HSA-444620 | map05310 | celastrol | 5478883 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | celastrol | 5478883 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | celastrol | 5478883 | drug-path |
Small cell lung cancer | R-HSA-5619066 | map05222 | celastrol | 5478883 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | celastrol | 5478883 | drug-path |
Shigellosis | 0 | map05131 | 5286656 | None | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | 5286656 | None | drug-path |
Gap junction | R-HSA-190861 | map04540 | 5286656 | None | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | 5286656 | None | drug-path |
Insulin signaling pathway | R-HSA-74752 | map04910 | 5286656 | None | drug-path |
Adherens junction | R-HSA-451386 | map04520 | 5286656 | None | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | 5286656 | None | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | 5286656 | None | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | 5286656 | None | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | 5286656 | None | drug-path |
Thyroid cancer | R-HSA-9700206 | map05216 | 5286656 | None | drug-path |
Adipocytokine signaling pathway | R-HSA-168638 | map04920 | 5286656 | None | drug-path |
ErbB signaling pathway | R-HSA-168638 | map04012 | 5286656 | None | drug-path |